Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >

PhinC Development


5, Rue Henri Desbruères – Campus 1 – Building 8
91030 EVRY-COURCOURONNES Cedex – FRANCE
Phone: +33 1 76 91 24 66
Email: contact@phinc.fr

CEO, co-founder: Bernard ORLANDINI
Web Site >
Phinc Development - Genopole's Company Phinc Development - Genopole's Company

#R&D Services and Products

  • Drug development
  • Modeling & simulation
  • Pharmacology
  • Pharmacokinetics
  • Biostatistics
  • Cardiac safety

Field of Activity


PhinC Development brings its expertise to small and mid-sized biotechs and pharmaceutical companies looking to advance their early-stage drug research.

BACKGROUND
PhinC Development launched its clinical pharmacology modeling activity in 2008 to bring complementary competencies and experience in clinical research to biotechs developing drug candidates.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
PhinC Development proposes predictive pharmacological models tailored to the biotech’s drug candidate to accelerate its development phases. The models offer novel perspectives enabling the anticipation of future development phases for the drug candidate and easing the analysis and interpretation of research results.

PARTNERSHIPS SOUGHT/h3>
PhinC seeks partnerships for the implementation of an integrated drug discovery platform to strengthen its drug candidate optimization activity..

  • Further Information

    Patents: Proprietary methodology and expertise
    21 staff members
    Strengths:
    More than 25 years of experience in early-stage drug development. Agility and biotech-centered: PhinC targets and tailors its services to the needs and specificities of biotechs.
    Innovation assets:
    Deep learning to develop the models the most apt for exploiting the totality of research data and providing robust simulations and predictions.

Share
Genopole’s Companies

#R&D Services and Products


In same field

Quibiotic - Projet Shaker

Quibiotic

Quibiotic develops three molecular synthesis platforms aimed at innovatively modifying β-lactam rings for new anti-infectives.

Discover
Maison M - Startup génopolitaine

Maison M

Personalized and sustainable Cosmetic House inspired by various and unique beauties. The innovative Maison M lipstick delivers any shade customized by its user.

Discover
Adlin - Entreprise génopolitaine - #IA Biotech

Adlin Science

ADLIN Science is a mission-driven company that strives to transform the life sciences sector by providing solutions to bring together public actors (institutes, hospitals, universities) and private actors (biotechs, pharma). Our innovative approach is to develop the first decentralized Digital Research Environment (fundamental, translational, and clinical) dedicated to the entire public and private ecosystem. ADLIN is the scientific trusted third-party among all actors in the sector with the ambition to accelerate innovation in healthcare while participating in research financing.

Discover
Altar - entreprise génopolitaine - intégre le groupe Ginko Bioworks

Altar

Ginkgo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Xentech - Genopole Company

XenTech

XenTech is an innovative biotech company specialized in the preclinical evaluation of cancer drugs and the identification of biomarkers and therapeutic targets.

Discover
Polytheragene - Genopole's Company

Polytheragene

Manufacture and sale of new high performance transfecting agents for gene therapy, high-throughput screening and biomanufacturing. Cosmetic and therapeutic molecules from plant biomass.

Discover
New england Biolabs - Genopole's Compny - 50 Years logo

New England Biolabs France

New England Biolabs is a private company manufacturing reagents for the life science industry particularly focused on products for genomic research.

Discover
Hybrigenics - Genopole's company

Hybrigenics Services

Hybrigenics Services proposes fee-for-services R&D support and provides innovative technological platforms for i) protein interaction studies (protein-protein, drug-protein, mechanisms of action) and ii) selection and validation of VHH antibodies.

Discover
logo abcell Bio - Genopole's Companie

ABCell-Bio

Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.

Discover
View all >
With the support from
Région île de France